Molecular recognition in the sphingosine 1-phosphate receptor family

Journal of Molecular Graphics and Modelling

Volumn 26, Issue 8, 2008, Pages 1189-1201

  Pham, Truc Chi T ^a   Fells Sr , James I ^a   Osborne, Daniel A ^a   North, E Jeffrey ^a   Naor, Mor M ^a   Parrill, Abby L ^a  

^a University of Memphis   (United States)

Author keywords

Computational model; Endothelial differentiation gene (EDG); G protein coupled receptor (GPCR); Ligand recognition; Sphingosine 1 phosphate (S1P)

Indexed keywords

COMPUTATIONAL METHODS; LIGANDS; MATHEMATICAL MODELS; PHOSPHATES;

COMPUTATIONAL MODEL; ENDOTHELIAL DIFFERENTIATION GENE (EDG); G PROTEIN-COUPLED RECEPTOR (GPCR); LIGAND RECOGNITION; SPHINGOSINE 1-PHOSPHATE (S1P);

MOLECULAR RECOGNITION;

AMMONIA; BENZIMIDAZOLE; CATION; PHENYL GROUP; RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 4 PHOSPHATE RECEPTOR; SULFUR;

ARTICLE; ATOM; DATA BASE; PHARMACOPHORE; POTENCY DISORDER; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR AFFINITY; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN BINDING; RECEPTORS, LYSOPHOSPHATIDIC ACID; RECEPTORS, LYSOSPHINGOLIPID; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 42749089941     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2007.11.001     Document Type: Article

References (46)

1. Spiegel A.M., and Weinstein L.S. Inherited diseases involving G proteins and G protein-coupled receptors. Ann. Rev. Med. 55 (2004) 27-39
2. Schoneberg T., Schulz A., Biebermann H., Hermsdorf T., Rompler H., and Sangkuhl K. Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol. Ther. 104 (2004) 173-206
3. Pierce K.L., Premont R.T., and Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell. Biol. 3 (2002) 639-650
4. Staff M.A.N. World's best-selling medicines. Med. Ad. News. 23 (2004) 60-64
5. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289 (2000) 739-745
6. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., and Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2, 2 A crystal structure. J. Mol. Biol. 342 (2004) 571-583
7. Becker O.M., Shacham S., Marantz Y., and Noiman S. Modeling the 3D structure of GPCRs: advances and application to drug discovery. Curr. Opin. Drug Discov. Dev. 6 (2003) 353-361
8. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J. Biol. Chem. 273 (1998) 27104-27110
9. Lee M.-J., Van Brocklyn J.R., Thangada S., Liu C.H., Hand A.R., Menzeleev R., Spiegel S., and Hla T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279 (1998) 1552-1555
10. An S., Bleu T., Huang W., Hallmark O.G., Coughlin S.R., and Goetzl E.J. Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids. FEBS Lett. 417 (1997) 279-282
11. Van Brocklyn J.R., Gräler M.H., Bernhardt G., Hobson J.P., and Spiegel S. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 95 (2000) 2624-2629
12. Yamazaki Y., Kon J., Sato K., Tomura H., Sato M., Yoneya T., Okazaki H., Okajima F., and Ohta H. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway. Biochem. Biophys. Res. Commun. 268 (2000) 583-589
13. Im D.-S., Heise C.E., Ancellin N., O'Dowd B.F., Shei G.-J., Heavens R.P., Rigby M.R., Hla T., Mandala S., McAllister G., George S.R., and Lynch K.R. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J. Biol. Chem. 275 (2000) 14281-14286
14. MacLennan A.J., Browe C.S., Gaskin A.A., Lado D.C., and Shaw G. Cloning and characterization of a putative G-protein coupled receptor potentially involved in development. Mol. Cell. Neurosci. 5 (1994) 201-209
15. Hla T., and Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 265 (1990) 9308-9313
16. i-coupled cell surface receptor A potential involvement in angiogenesis. J. Biol. Chem. 274 (1999) 35343-35350
17. Kupperman E., An S., Osborne N., Waldron S., and Stainier D.Y.R. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature 406 (2000) 192-195
18. English D., Garcia J.G., and Brindley D.N. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 49 (2001) 588-599
19. Erl W., and Siess W. Sphingosine-1-phosphate and the leading edg-1 of vascular smooth muscle cells. Circ. Res. 89 (2001) 474-476
20. Rosenfeldt H.M., Hobson J.P., Macyka M., Olivera A., Nava V.E., Milstien S., and Spiegel S. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. FASEB J. 15 (2001) 2649-2659
21. Tamama K., Kon J., Sato K., Tomura H., Kuwabara A., Kimura T., Kanda T., Ohta H., Ui M., Kobayashi I., and Okajima F. Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. Biochem. J. 353 (2001) 139-146
22. Kwon Y.G., Min J.K., Kim K.M., Lee D.J., Billiar T.R., and Kim Y.M. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem. 276 (2001) 10627-10633
23. Hisano N., Yatomi Y., Satoh K., Akimoto S., Mitsumata M., Fujino M.A., and Ozaki Y. Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. Blood 93 (1999) 4293-4299
24. Cavallini L., Venerando R., Miotto G., and Alexandre A. Ganglioside GM1 protection from apoptosis of rat heart fibroblasts. Arch. Biochem. Biophys. 370 (1999) 156-162
25. Morita Y., Perez G.I., Paris F., Miranda S.R., Ehleiter D., Haimovitz-Friedman A., Fuks Z., Xie Z., Reed J.C., Schuchman E.H., Kolesnick R.N., and Tilly J.L. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med. 6 (2000) 1109-1114
26. Mandala S., Hajdu R., Bergstrom J., Quackenbush E., Xie J., Milligan J., Thornton R., Shei G.J., Card D., Keohane C., Rosenbach M., Hale J., Lynch C.L., Rupprecht K., Parsons W., and Rosen H. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296 (2002) 346-349
27. Brinkmann V., Pinschewer D.D., Feng L., and Chen S. FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 72 (2001) 764-769
28. 4 within the endothelial differentiation gene family of receptors. Biochem. J. 389 (2005) 187-195
29. 1 receptor. J. Biol. Chem. 282 (2007) 2374-2385
30. 1 (EDG2) phospholipid growth factor receptors. J. Biol. Chem. 276 (2001) 49213-49220
31. Berman H., Henrick K., and Nakamura H. Announcing the worldwide Protein Data Bank. Nat. Struct. Biol. 10 (2003) 980
32. Pham T.C., Kriwacki R.W., and Parrill A.L. Peptide design and structural characterization of a GPCR loop mimetic. Biopolymers 86 (2007) 298-310
33. MOE, Chemical Computing Group: Montreal, 2003.
34. Halgren T.A. Merck molecular force field. I. Basis form, scope parameterization, and performance of MMFF94*. J. Comput. Chem. 17 5/6 (1996) 490-519
35. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19 (1998) 1639-1662
36. 1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem. Biol. 12 (2005) 703-715
37. Hale J.J., Lynch C.L., Neway W., Mills S.G., Hajdu R., Keohane C.A., Rosenbach M.J., Milligan J.A., Shei G.J., Parent S.A., Chrebet G., Bergstrom J., Card D., Ferrer M., Hodder P., Strulovici B., Rosen H., and Mandala S. A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists. J. Med. Chem. 47 (2004) 6662-6665
38. 4 receptor agonists. Bioorg. Med. Chem. Lett. 14 (2004) 4903-4906
39. Reid K.S.C., Lindley P.F., and Thornton J.M. Sulfur-aromatic interactions in proteins. FEBS Lett. 190 (1985) 209-213
40. Lim H.S., Oh Y.S., Suh P.G., and Chung S.K. Syntheses of sphingosine-1-phosphate stereoisomers and analogues and their interaction with EDG receptors. Bioorg. Med. Chem. Lett. 13 (2003) 237-240
41. Lim H.S., Park J.J., Ko K., Lee M.H., and Chung S.K. Syntheses of sphingosine-1-phosphate analogues and their interaction with EDG/S1P receptors. Bioorg. Med. Chem. Lett. 14 (2004) 2499-2503
42. 4 receptor. BMC Biochem. 5 (2004) 12
43. 3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279 (2004) 13839-13848
44. Vaidehi N., Floriano W.B., Trabanino R., Hall S.E., Freddolino P., Choi E.J., Zamanakos G., and Goddard W.A.I. Prediction of structure and function of G protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12622-12627
45. Zhang Y., Devries M.E., and Skolnick J. Structure modeling of all identified G protein-coupled receptors in the human genome. PLoS Comput. Biol. 2 (2006) e13
46. Naor M.M., Walker M.D., Van Brocklyn J.R., Tigyi G., and Parrill A.L. Sphingosine 1-phosphate pK(a) and binding constants: intramolecular and intermolecular influences. J. Mol. Graph. Model. 26 (2007) 519-528